- Home
- QMCO vs BNTC Comparison
QMCO vs BNTC Comparison
Compare QMCO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- BNTC
- Stock Information
- Founded
- QMCO 1980
- BNTC 1995
- Country
- QMCO United States
- BNTC United States
- Employees
- QMCO N/A
- BNTC N/A
- Industry
- QMCO Electronic Components
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- QMCO Technology
- BNTC Health Care
- Exchange
- QMCO Nasdaq
- BNTC Nasdaq
- Market Cap
- QMCO 83.2M
- BNTC 88.1M
- IPO Year
- QMCO N/A
- BNTC N/A
- Fundamental
- Price
- QMCO $53.81
- BNTC $12.11
- Analyst Decision
- QMCO Hold
- BNTC Buy
- Analyst Count
- QMCO 2
- BNTC 6
- Target Price
- QMCO $5.00
- BNTC $23.83
- AVG Volume (30 Days)
- QMCO 6.2M
- BNTC 52.1K
- Earning Date
- QMCO 12-24-2024
- BNTC 02-11-2025
- Dividend Yield
- QMCO N/A
- BNTC N/A
- EPS Growth
- QMCO N/A
- BNTC N/A
- EPS
- QMCO N/A
- BNTC N/A
- Revenue
- QMCO $285,238,000.00
- BNTC N/A
- Revenue This Year
- QMCO N/A
- BNTC N/A
- Revenue Next Year
- QMCO N/A
- BNTC N/A
- P/E Ratio
- QMCO N/A
- BNTC N/A
- Revenue Growth
- QMCO N/A
- BNTC N/A
- 52 Week Low
- QMCO $2.22
- BNTC $2.69
- 52 Week High
- QMCO $33.00
- BNTC $13.29
- Technical
- Relative Strength Index (RSI)
- QMCO 71.54
- BNTC 62.51
- Support Level
- QMCO $16.62
- BNTC $11.36
- Resistance Level
- QMCO $31.00
- BNTC $13.29
- Average True Range (ATR)
- QMCO 4.66
- BNTC 0.96
- MACD
- QMCO 0.74
- BNTC 0.23
- Stochastic Oscillator
- QMCO 69.10
- BNTC 86.05
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.